Skip to Content

Loteprednol Etabonate 0.5% Ophthalmic Suspension

Last Updated: March 20, 2014
Status: Resolved

Products Affected - Description

Lotemax 0.5% ophthalmic suspension, Bausch & Lomb, Division of Valeant Pharmaceuticals
5 mL bottle (NDC 24208-0299-05) - discontinued
10 mL bottle (NDC 24208-0299-10) - discontinued
15 mL bottle (NDC 24208-0299-15) - discontinued

Reason for the Shortage

  • Valeant Pharmaceuticals discontinued Lotemax 0.5% ophthalmic suspension in February 2014 because of the anticipated release of the generic product in April 2014.
  • Valeant Pharmaceuticals acquired Bausch & Lomb in August 2013.
  • Supplies of Alrex (loteprednol 0.2% ophthalmic suspension) and Zylet (loteprednol 0.5% and tobramycin 0.3% ophthalmic suspension) are not affected and continue to be available.

Available Products

Lotemax 0.5% ophthalmic gel, Bausch & Lomb, Division of Valeant Pharmaceuticals
5 grams in 10 mL bottle (NDC 24208-0503-07)

Lotemax 0.5% ophthalmic ointment, Bausch & Lomb, Division of Valeant Pharmaceuticals
3.5 gram tube (NDC 24208-0443-35)

Estimated Resupply Dates

All presentations are currently available.

Related Shortages

Updated

March 20, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide